193 related articles for article (PubMed ID: 23437083)
1. Bayesian approach to model CD137 signaling in human M. tuberculosis in vitro responses.
Fernández Do Porto DA; Auzmendi J; Peña D; García VE; Moffatt L
PLoS One; 2013; 8(2):e55987. PubMed ID: 23437083
[TBL] [Abstract][Full Text] [Related]
2. CD137 differentially regulates innate and adaptive immunity against Mycobacterium tuberculosis.
Fernández Do Porto DA; Jurado JO; Pasquinelli V; Alvarez IB; Aspera RH; Musella RM; García VE
Immunol Cell Biol; 2012 Apr; 90(4):449-56. PubMed ID: 21747409
[TBL] [Abstract][Full Text] [Related]
3. Role of the CD137 ligand (CD137L) signaling pathway during Mycobacterium tuberculosis infection.
Martínez Gómez JM; Koh VH; Yan B; Lin W; Ang ML; Rahim SZ; Pethe K; Schwarz H; Alonso S
Immunobiology; 2014 Jan; 219(1):78-86. PubMed ID: 24091276
[TBL] [Abstract][Full Text] [Related]
4. Induction of CD137 expression by viral genes reduces T cell costimulation.
Wu M; Wong HY; Lin JL; Moliner A; Schwarz H
J Cell Physiol; 2019 Nov; 234(11):21076-21088. PubMed ID: 31025383
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis.
Luu K; Patwardhan MV; Zeng Q; Wickström SL; Lundqvist A; Schwarz H
Cells; 2021 Feb; 10(2):. PubMed ID: 33572150
[TBL] [Abstract][Full Text] [Related]
6. CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases.
Wong HY; Schwarz H
J Autoimmun; 2020 Aug; 112():102499. PubMed ID: 32505443
[TBL] [Abstract][Full Text] [Related]
7. CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells.
Baessler T; Charton JE; Schmiedel BJ; Grünebach F; Krusch M; Wacker A; Rammensee HG; Salih HR
Blood; 2010 Apr; 115(15):3058-69. PubMed ID: 20008791
[TBL] [Abstract][Full Text] [Related]
8. CD137 (4-1BB) Engagement Fine-Tunes Synergistic IL-15- and IL-21-Driven NK Cell Proliferation.
Vidard L; Dureuil C; Baudhuin J; Vescovi L; Durand L; Sierra V; Parmantier E
J Immunol; 2019 Aug; 203(3):676-685. PubMed ID: 31201235
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand.
Kang SW; Lee SC; Park SH; Kim J; Kim HH; Lee HW; Seo SK; Kwon BS; Cho HR; Kwon B
Cancer Res; 2017 Nov; 77(21):5989-6000. PubMed ID: 28923858
[TBL] [Abstract][Full Text] [Related]
10. CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging.
Tang Q; Koh LK; Jiang D; Schwarz H
Aging (Albany NY); 2013 Sep; 5(9):643-52. PubMed ID: 23945137
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CD137 ligand signaling in neural stem cell death.
Yun CH; Lee HM; Lee SC; Kim BS; Park JW; Lee BJ
Mol Cells; 2013 Sep; 36(3):245-51. PubMed ID: 23925549
[TBL] [Abstract][Full Text] [Related]
12. The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity.
Choi BK; Lee HW
Front Immunol; 2020; 11():553715. PubMed ID: 33362756
[TBL] [Abstract][Full Text] [Related]
13. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.
Maniar A; Zhang X; Lin W; Gastman BR; Pauza CD; Strome SE; Chapoval AI
Blood; 2010 Sep; 116(10):1726-33. PubMed ID: 20519625
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling.
Gullo C; Koh LK; Pang WL; Ho KT; Tan SH; Schwarz H
PLoS One; 2010 May; 5(5):e10845. PubMed ID: 20520765
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of CD137 signaling and CD137L reverse signaling in atherosclerosis].
Yin YJ; Zhong W; Yan JC
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):557-60. PubMed ID: 27346273
[No Abstract] [Full Text] [Related]
16. CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses.
Vinay DS; Choi BK; Bae JS; Kim WY; Gebhardt BM; Kwon BS
J Immunol; 2004 Sep; 173(6):4218-29. PubMed ID: 15356173
[TBL] [Abstract][Full Text] [Related]
17. CD137-CD137L Signaling Affects Angiogenesis by Mediating Phenotypic Conversion of Macrophages.
Xu Y; Yan Y; Geng T; Wang C; Xu Y; Yang P; Yan J
J Cardiovasc Pharmacol; 2020 Feb; 75(2):148-154. PubMed ID: 31651672
[TBL] [Abstract][Full Text] [Related]
18. Rationale for anti-CD137 cancer immunotherapy.
Makkouk A; Chester C; Kohrt HE
Eur J Cancer; 2016 Feb; 54():112-119. PubMed ID: 26751393
[TBL] [Abstract][Full Text] [Related]
19. Identification of CD137- and CD137L-Expressing Cells in EL-4 Tumor.
Kang SW; Cho HR; Kwon B
Methods Mol Biol; 2021; 2248():221-229. PubMed ID: 33185879
[TBL] [Abstract][Full Text] [Related]
20. CD137-CD137L interaction modulates neointima formation and the phenotype transformation of vascular smooth muscle cells via NFATc1 signaling.
Zhong W; Li B; Yang P; Chen R; Wang C; Wang Z; Shao C; Yuan W; Yan J
Mol Cell Biochem; 2018 Feb; 439(1-2):65-74. PubMed ID: 28770466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
